Eburnalritardo

CAS No. 4880-88-0

Eburnalritardo( CH846 | CH-846 | CH 846 | Vinburnine | Eburnal | Eburnamonine )

Catalog No. M14640 CAS No. 4880-88-0

Vinburnine (or eburnamonine, Vincamone) is a vasodilator. Vincamone is a vinca alkaloid and a metabolite of vincamine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 37 In Stock
50MG 51 In Stock
100MG 74 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Eburnalritardo
  • Note
    Research use only, not for human use.
  • Brief Description
    Vinburnine (or eburnamonine, Vincamone) is a vasodilator. Vincamone is a vinca alkaloid and a metabolite of vincamine.
  • Description
    Vinburnine (or eburnamonine, Vincamone) is a vasodilator. Vincamone is a vinca alkaloid and a metabolite of vincamine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CH846 | CH-846 | CH 846 | Vinburnine | Eburnal | Eburnamonine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    4880-88-0
  • Formula Weight
    294.39
  • Molecular Formula
    C19H22N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C1N2C3=C(C4=C2C=CC=C4)CCN5C3[C@@](CCC5)(CC)C1
  • Chemical Name
    (13aR)-13a-ethyl-2,3,5,6,13,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12(41H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Riofski MV, et al. J Org Chem. 2011 May 20; 76(10):3676-83.
molnova catalog
related products
  • Phe-Lys(Trt)-PAB

    Phe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

  • BAD (103 - 126), hum...

    BAD (103 - 126), human

  • Elgodipine

    Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun.